Godavari Drugs

Small Cap 1.6k Result

₹91.5

-1.35 (-1.45%)

As on 01 October, 2023 | 11:20 BSE: 530317 NSE: GODAVARIISIN: INE362C01012

Godavari Drugs Performance

Day Range

Low
High

91.5

52 Week Range

Low
High

91.5

Open Price
Previous Close
Volume

Start SIP in Godavari Drugs

Start SIP

Godavari Drugs Share Price

Over 1 Month -10.69%
Over 3 Month -5.46%
Over 6 Month 17.41%
Over 1 Year 36.36%

Godavari Drugs Key Statistics

Godavari Drugs Investment Rating

Master Rating:
Godavari Drugs has an operating revenue of Rs. 152.49 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 11% is good. The company has a reasonable debt to equity of 36%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Godavari Drugs Financials

Standalone Consolidated

Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios

Indicator	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Oper Rev Qtr Cr	35	37	39	41	43	44
Operating Expenses Qtr Cr	33	35	37	38	40	42
Operating Profit Qtr Cr	2	3	2	3	2	3
Depreciation Qtr Cr	0	0	1	0	0	0
Interest Qtr Cr	1	1	1	1	1	1
Tax Qtr Cr	0	0	0	0	0	1
Net Profit Qtr Cr	1	1	1	1	1	1

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr	160	161
Operating Expenses Annual Cr	150	150
Operating Profit Annual in Cr	10	11
Depreciation Cr	2	2
Interest Annual Cr	4	3
Tax Annual Cr	1	2
Net Profit Annual Cr	4	5

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr	13	11
Cash from Investing Activity Annual Cr	-9	-5
Cash from Financing Annual Activity Cr	-4	-6
Net Cash Flow Annual Cr	1	1

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr	33	30
Fixed Assets Annual Cr	34	27
Total Non Current Assets Annual Cr	34	27
Total Current Assets Annual Cr	87	74
Total Assets Annual Cr	121	101

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs	44	39
ROE Annual %	11	18
ROCE Annual %	18	23
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	7	7

Indicator	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %

Godavari Drugs Technicals

EMA & SMA

Current Price

₹91.5

-1.35 (-1.45%)

Bullish Moving Average
___
3

Bearish Moving Average
___
13

EMA SMA

20 Day
₹98.35

50 Day
₹98.89

100 Day
₹95.51

200 Day
₹89.19

20 Day
₹100.74

50 Day
₹100.84

100 Day
₹95.47

200 Day
₹88.93

Godavari Drugs Resistance and Support

PIVOT

₹92.32

Resistance
First Resistance	₹94.14
Second Resistance	₹96.77
Third Resistance	₹98.59

RSI	35.71
MFI	35.71
MACD Single Line	-1.2
MACD	-2.31

Support
First Resistance	₹89.69
Second Resistance	₹87.87
Third Resistance	₹85.24

Godavari Drugs Delivery and Volume

Period	NSE + BSE Volume Avg	NSE + BSE Delivery Volume Avg	NSE + BSE Delivery Volume %
Day	22,869	1,780,580	77.86
Week	15,730	1,140,582	72.51
1 Month	25,100	1,750,497	69.74
6 Month	23,392	1,627,390	69.57

Godavari Drugs Result Highlights

Godavari Drugs Synopsis

BSE-Medical-Generic Drugs

Godavari Drugs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 159.62 Cr. and Equity Capital is Rs. 7.53 Cr. for the Year ended 31/03/2023. Godavari Drugs Ltd. is a Public Limited Listed company incorporated on 02/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1987PLC008016 and registration number is 008016.

Market Cap	69
Sales	152
Shares in Float	0.35
No of funds	4
Yield

Book Value	2.06
U/D Vol ratio	1.4
LTDebt / Equity	36
Alpha	0.16
Beta	0.22

Godavari Drugs

Owner Name	Jun-23	Mar-23	Dec-22	Sep-22
Promoters	53.16%	53.12%	53.12%	56.92%
Financial Institutions/ Banks	0.5%	0.5%	0.5%	0.5%
Individual Investors	38.75%	7.27%	39.26%	35.9%
Others	7.59%	39.11%	7.12%	6.68%

Godavari Drugs Management

Name	Designation
Mr. Ghanshyam Jaju	Chairman
Mr. Mukund Kakani	Managing Director
Mr. Mohit Jaju	WholeTime Director & CFO
Mr. Mahendra Bhalerao	Non Exe. & Ind. Director
Mr. Dilip Keshavlal Patel	Independent Director
Mr. Syed Anis Hussain	Non Exe. & Ind. Director
Mr. Ramesh Babu Telugu	Non Exe. & Ind. Director
Mrs. Vimala Madon	Non Exe. & Ind. Director